Evaluation of the effect of nut consumption on energy balance, metabolic, inflammatory response and oxidation

ISRCTN ISRCTN36468613
DOI https://doi.org/10.1186/ISRCTN36468613
Secondary identifying numbers AGL2005-03605
Submission date
01/06/2006
Registration date
19/06/2006
Last edited
02/12/2010
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nutritional, Metabolic, Endocrine
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English Summary

Not provided at time of registration

Contact information

Dr Jordi Salas-Salvadó
Scientific

C/Sant Llorenç 21
Reus
43201
Spain

Phone +34 (0)97 775 93 13
Email jordi.salas@urv.net

Study information

Study designRandomised controlled clinical trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeTreatment
Scientific title
Study acronymEFINUT
Study hypothesisRegular nut consumption improves cardiovascular risk factors in metabolic syndrome patients without adverse effects on energy balance and insulin sensitivity
Ethics approval(s)Approved by Sant Joan Hospital Ethical Committee, reference number: EFINUT-05-01-27/1proj2
ConditionMetabolic syndrome
InterventionParticipants are randomly assigned into two equal groups:
1. Control group: low-fat diet according to American Heart Association guidelines
2. Nut group: low-fat diet according to American Heart Association guidelines with an added 30 g/day of nuts
Intervention typeOther
Primary outcome measurePeripheral inflammatory markers
Secondary outcome measures1. Stress oxidative markers
2. Endothelial function
3. Insulin sensitivity
4. Energy balance
Overall study start date08/01/2006
Overall study end date31/12/2007

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants50; male and female
Participant inclusion criteriaPatients with metabolic syndrome aged between 18 and 65 years
Participant exclusion criteria1. Nut allergy
2. Type 2 diabetes
3. Body mass index (BMI) >33 kg/m^2
4. Secondary obesity
5. Inflammatory or infectious disease
6. Anti-inflammatory or antibiotic drugs
7. Alcoholism or drug abuse
8. Recent hypocaloric diet
Recruitment start date08/01/2006
Recruitment end date31/12/2007

Locations

Countries of recruitment

  • Spain

Study participating centre

C/Sant Llorenç 21
Reus
43201
Spain

Sponsor information

Ministry of Education and Science (Ministerio de Educacion y Ciencia) (Spain)
Government

Paseo de la Castellana
160 Pta 12
Madrid
28071
Spain

Phone +34 (0)91 349 40 00
Email dtcv@mec.es
Website http://www.mec.es

Funders

Funder type

Government

Ministry of Education and Science (Ministerio de Educacion y Ciencia)
Government organisation / Local government
Alternative name(s)
Ministry of Education and Science, MEC
Location
Portugal
International Nut Council

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/06/2010 Yes No